Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma

NCT00734318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1667

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma, Bronchial

Interventions

DRUG: Flutiform 250/10 micrograms
DRUG: Flutiform 50/5 micrograms
DRUG: Flixotide pMDI 250 mcg + foradil pMDI 24 micrograms
DRUG: Flixotide pMDI 250 micrograms

Sponsor

Mundipharma Research Limited